335 related articles for article (PubMed ID: 25729470)
1. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.
Schütte K; Schulz C; Link A; Malfertheiner P
World J Hepatol; 2015 Feb; 7(2):139-49. PubMed ID: 25729470
[TBL] [Abstract][Full Text] [Related]
2. Serum Biomarkers for the Prediction of Hepatocellular Carcinoma.
Debes JD; Romagnoli PA; Prieto J; Arrese M; Mattos AZ; Boonstra A; On Behalf Of The Escalon Consortium
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918270
[TBL] [Abstract][Full Text] [Related]
3. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
[TBL] [Abstract][Full Text] [Related]
4. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
Tayob N; Richardson P; White DL; Yu X; Davila JA; Kanwal F; Feng Z; El-Serag HB
BMC Med Res Methodol; 2018 Jan; 18(1):1. PubMed ID: 29301497
[TBL] [Abstract][Full Text] [Related]
5. Dynamic edge-based biomarker non-invasively predicts hepatocellular carcinoma with hepatitis B virus infection for individual patients based on blood testing.
Lu Y; Fang Z; Li M; Chen Q; Zeng T; Lu L; Chen Q; Zhang H; Zhou Q; Sun Y; Xue X; Hu Y; Chen L; Su S
J Mol Cell Biol; 2019 Aug; 11(8):665-677. PubMed ID: 30925583
[TBL] [Abstract][Full Text] [Related]
6. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.
Anwar SL; Lehmann U
J Clin Med; 2015 Aug; 4(8):1631-50. PubMed ID: 26295264
[TBL] [Abstract][Full Text] [Related]
8. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
[TBL] [Abstract][Full Text] [Related]
9. dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling.
Ouyang J; Sun Y; Li W; Zhang W; Wang D; Liu X; Lin Y; Lian B; Xie L
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2688-95. PubMed ID: 26940364
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.
Jiang HY; Chen J; Xia CC; Cao LK; Duan T; Song B
World J Gastroenterol; 2018 Jun; 24(22):2348-2362. PubMed ID: 29904242
[TBL] [Abstract][Full Text] [Related]
11. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
12. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers.
Ayoub WS; Steggerda J; Yang JD; Kuo A; Sundaram V; Lu SC
Ther Adv Med Oncol; 2019; 11():1758835919869120. PubMed ID: 31523283
[TBL] [Abstract][Full Text] [Related]
13. Novel biomarkers for hepatocellular carcinoma surveillance: has the future arrived?
Gonzalez SA
Hepatobiliary Surg Nutr; 2014 Dec; 3(6):410-4. PubMed ID: 25568864
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers in hepatocellular carcinoma: an overview.
Juárez-Hernández E; Motola-Kuba D; Chávez-Tapia NC; Uribe M; Barbero Becerra V
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):549-558. PubMed ID: 28347162
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.
Romano M; De Francesco F; Pirozzi G; Gringeri E; Boetto R; Di Domenico M; Zavan B; Ferraro GA; Cillo U
Oncoscience; 2015; 2(5):443-456. PubMed ID: 26097877
[TBL] [Abstract][Full Text] [Related]
16. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.
Wang T; Zhang KH
Front Oncol; 2020; 10():1316. PubMed ID: 32923383
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives.
Pan Y; Chen H; Yu J
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33297335
[TBL] [Abstract][Full Text] [Related]
18. Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation.
Gao J; Song P
Drug Discov Ther; 2017; 11(3):168-169. PubMed ID: 28757516
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
Cai J; Li B; Zhu Y; Fang X; Zhu M; Wang M; Liu S; Jiang X; Zheng J; Zhang X; Chen P
EBioMedicine; 2017 May; 19():18-30. PubMed ID: 28434945
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
